Objective To synthesise lessons learnt and determinants of success from human
papillomavirus (HPV) vaccine demonstration projects and national programmes in low-and …

Background: Rapid changes in lifestyle induced by globalization have brought about
changes in sexual behaviour, especially among younger generations. These changes may …

BACKGROUND: Since 2006 Human papillomavirus (HPV) vaccination has become
available to adolescent girls and women in an increasing number of countries, to protect …

Human papillomavirus (HPV) is the causative agent in cervical cancer and has been
implicated in a range of other malignancies. Preventative vaccines are now internationally …

More than 90% of cervical cancer deaths occur in low-and middle-income countries (LMICs),
which have limited capacity to mount the comprehensive national screening and precancer …

Objectives We assessed the knowledge and awareness of cervical cancer, HPV and HPV
vaccine, and willingness and acceptability to vaccinate in sub-Saharan African (SSA) …

Abstract Background Human Papilloma Virus (HPV) vaccine has undergone successful
trials and has recently been approved for use for the primary prevention of cervical cancer …

Background: The introduction of human papillomavirus (HPV) vaccines represents a
breakthrough in the primary prevention of cervical cancer. However, little is known about …

Compared to other regions of the world, sub-Saharan Africa has made limited progress in
the implementation and performance of nationwide human papillomavirus (HPV) …

Background Since the introduction of HPV vaccines, several studies have been conducted
in different countries to assess HPV knowledge and vaccine acceptance. The aim of this …